about
sameAs
The contribution of major depression to the global burden of ischemic heart disease: a comparative risk assessmentGlobal, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transitionDisability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013: Findings From the Global Burden of Disease 2013 StudyDonor Financing of Global Mental Health, 1995-2015: An Assessment of Trends, Channels, and Alignment with the Disease Burden.Systematic review of interventions for Indigenous adults with mental and substance use disorders in Australia, Canada, New Zealand and the United States.The burden of mental, neurological, and substance use disorders in China and India: a systematic analysis of community representative epidemiological studies.Child and Adolescent Health From 1990 to 2015: Findings From the Global Burden of Diseases, Injuries, and Risk Factors 2015 Study.Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas.Should global burden of disease estimates include depression as a risk factor for coronary heart disease?A systematic review of research examining benzodiazepine-related mortality.Mental disorders as risk factors: assessing the evidence for the Global Burden of Disease Study.Mental and substance use disorders in Sub-Saharan Africa: predictions of epidemiological changes and mental health workforce requirements for the next 40 yearsPredicting the impact of the 2011 conflict in Libya on population mental health: PTSD and depression prevalence and mental health service requirements.The epidemiological modelling of major depressive disorder: application for the Global Burden of Disease Study 2010.Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010.Applications of the epidemiological modelling outputs for targeted mental health planning in conflict-affected populations: the Syria case-study.Post-traumatic stress disorder and major depression in conflict-affected populations: an epidemiological model and predictor analysisECT efficacy and treatment course: a systematic review and meta-analysis of twice vs thrice weekly schedules.How did we arrive at burden of disease estimates for mental and illicit drug use disorders in the Global Burden of Disease Study 2010?Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010.Social correlates of mental, neurological, and substance use disorders in China and India: a review.Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition.Burden of mental and substance use disorders in Indigenous Australians and Oceania.The prevalence and service utilisation associated with mental and substance use disorders in Lao People's Democratic Republic: findings from a cross-sectional survey.Evaluation of a Leadership in Mental Health course for Pacific Island Nation delegates.Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013.Prevalence of mental, neurological, and substance use disorders in China and India: a systematic analysis.Re: Meta-analysis of Australian Indigenous psychiatric treatment, critiqued.Time-course of PTSD symptoms in the Australian Defence Force: a retrospective cohort study.The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study.The prevalence and burden of mental and substance use disorders in Australia: Findings from the Global Burden of Disease Study 2015.Twice versus thrice weekly ECT in a clinical population: an evaluation of patient outcomes.Excess mortality from mental, neurological and substance use disorders in the Global Burden of Disease Study 2010.The global burden of mental and substance use disorders: changes in estimating burden between GBD1990 and GBD2010.The State of US Health, 1990-2016: Burden of Diseases, Injuries, and Risk Factors Among US States.
P50
Q21245288-0E84841B-6436-4501-B978-4EFBB165DA20Q24170269-2FB57993-A368-427C-88E4-AA61B84871CCQ27860791-EE69C616-15FF-463F-AE40-AA64E8D7B0DAQ27860879-6EF85F3B-318F-4AC7-8C71-E58EFDA3D9ABQ28111913-DD901B96-DD81-4605-8070-FCD4C32BE54EQ28392340-8D6876D5-456F-42FC-B502-D1CC2A4F0ED0Q29247966-BB24AF31-C994-4B65-91C2-2B1740B76123Q30242049-B7AA06ED-989A-47AC-911B-9F12A30AF388Q30250241-D5A9116F-92EE-480F-A18E-25BB2BCBBCE7Q30252707-8CB04096-8377-48DA-9C63-8AC406F64024Q30358426-1488A431-1877-4B17-A889-F57FCE8A1AD1Q30379171-7209E174-65DC-4453-A7C0-44356FF56A35Q33888699-9AC85A88-3966-4090-894F-6BB01F086E5BQ34015527-E2AB207A-09E3-4E51-9B6A-756AE11092E8Q34103927-E199A9B4-7882-404B-88BC-F14E443903CEQ34332269-6B1F5F71-B0BB-43B3-B179-72E75F8A368CQ34342150-7942FEE0-6A57-43CD-9AC5-DAA126C59DC2Q34903396-1DC61904-AE24-44DD-8229-8DC83DBF6716Q35040553-6C02E3FA-1EB0-46E9-83C9-8A577D2AEA6EQ37649427-D914C769-B175-4CB2-BD68-AA19914BE178Q37649430-69E4548A-9EAA-4910-B602-B7C272DE644BQ37866475-478C2038-CC38-4B1F-9266-DD2DCF35C171Q38108157-FDA6F888-F3BD-4977-970E-0348EBCBAEB0Q38133045-C18746FD-8068-446F-B692-27C1296B3659Q38133047-EF174571-12B6-47BF-A275-E5F64857798AQ38388831-42162761-2DF3-4271-9FC1-A780A30DB524Q38603745-3909FC84-8DDD-4DC2-954E-08E2FDEF44E1Q38658467-CD131F36-947B-449F-BEFA-5E1F7E7A19ABQ38666161-FFB6C3BA-8EF9-47B5-A356-D21A80F44BD5Q38935572-25077DA4-7256-4076-98E7-286A03737C85Q39354156-11DD6386-50FA-4C8C-8410-85FBBB9BCF5DQ39487501-FF4FB97D-9795-421C-A376-377EA946A6FBQ40080174-BC4C80BD-3018-46EA-8809-FCE5B039C0A6Q40836044-78D26E14-1C6A-4B09-A380-B44D0F5E9C69Q44344114-977EDA71-C56E-4315-91B8-30289D4873F1Q47556798-13B6446A-6A76-42A6-8E2A-7040B28BE518Q48701990-5F04920F-2FE3-4E45-A05A-77F4E738E89BQ50606762-1086FEA6-B7BB-4FB4-B441-0B5EFBFEEBB1Q50647404-8D4BFDCC-8ED2-452C-AAF7-0AFC12C63A78Q52596402-5AD0A7C7-FC74-445F-98E7-F187389C1640
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Fiona Charlson
@ast
Fiona Charlson
@en
Fiona Charlson
@es
Fiona Charlson
@nl
Fiona Charlson
@sl
type
label
Fiona Charlson
@ast
Fiona Charlson
@en
Fiona Charlson
@es
Fiona Charlson
@nl
Fiona Charlson
@sl
altLabel
Charlson F
@en
Charlson FJ
@en
F Charlson
@en
F J Charlson
@en
Fiona J Charlson
@en
prefLabel
Fiona Charlson
@ast
Fiona Charlson
@en
Fiona Charlson
@es
Fiona Charlson
@nl
Fiona Charlson
@sl
P1053
F-5290-2011
P106
P1153
57191632086
P21
P31
P3829
P496
0000-0003-2876-5040